HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

4- hydroxy- 2- (hydroxymethyl)pyrrolidin- 3- yl 4- O- (6- deoxyglucopyranosyl)glucopyranoside

structure in first source

Also Known As:

4-hydroxy-2-(hydroxymethyl)pyrrolidin-3-yl 4-O-(6-deoxy-beta-D-glucopyranosyl)-alpha-D-glucopyranoside; CS-1036

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Polysaccharides: 15383
  - Oligosaccharides: 3566
    - Disaccharides: 990
      - 4-hydroxy-2-(hydroxymethyl)pyrrolidin-3-yl 4-O-(6-deoxyglucopyranosyl)glucopyranoside: 1
- Sugars: 11126
  - Disaccharides: 990
    - 4-hydroxy-2-(hydroxymethyl)pyrrolidin-3-yl 4-O-(6-deoxyglucopyranosyl)glucopyranoside: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrrolidines: 115
    - 4-hydroxy-2-(hydroxymethyl)pyrrolidin-3-yl 4-O-(6-deoxyglucopyranosyl)glucopyranoside: 1

Experts

1.	Honda, Tomohiro: 1 article (04/2013)
2.	Izumi, Takashi: 1 article (04/2013)
3.	Kakuta, Masayo: 1 article (04/2013)
4.	Kaneno-Urasaki, Yoko: 1 article (04/2013)
5.	Koga, Tetsufumi: 1 article (04/2013)
6.	Murai, Takahiro: 1 article (04/2013)
7.	Namba, Eiko: 1 article (04/2013)
8.	Nasu, Hatsumi: 1 article (04/2013)
9.	Okuno, Akira: 1 article (04/2013)

Related Diseases

1.

04/01/2013 - "In Zucker diabetic fatty rats, CS-1036 showed a suppressive effect on plasma glucose elevation after starch loading with a 50% effective dose at 0.015 mg/kg. In summary, CS-1036 showed optimal pharmacokinetic profiles: low oral absorption and favorable stability in gastrointestinal lumen, resulting in suppression of postprandial hyperglycemia by α-amylase inhibition."

Related Drugs and Biologics

1.	Starch (Cornstarch)
2.	Glucose (Dextrose)
3.	Amylases